Evolent Health/EVH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Evolent Health

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

Ticker

EVH

Sector

Healthcare

Trading on

NYSE

Industry

Healthcare Facilities

CEO

Seth Blackley

Employees

4,700

Headquarters

Arlington, United States

Evolent Health Metrics

BasicAdvanced
$2.5B
Market cap
-
P/E ratio
-$1.25
EPS
1.44
Beta
-
Dividend rate
$2.5B
1.43855
$35.00
$20.54
1.1M
1.016
48.64
48.64
-0.05%
-4.22%
-13.02%
-5.36%
1.132
2.318
18.881
46.76%
-228.32%
28.54%

What the Analysts think about Evolent Health

Analyst Ratings

Majority rating from 15 analysts.
Buy

Evolent Health Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-2.68% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$640M
15.04%
Net income
-$17M
-48.50%
Profit margin
-2.68%
-55.33%

Evolent Health Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 41.03%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.14
$0.30
$0.23
$0.34
-
Expected
$0.11
$0.07
$0.15
$0.24
$0.26
Surprise
24.05%
337.50%
54.48%
41.03%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Evolent Health stock?

Evolent Health (EVH) has a market cap of $2.5B as of June 19, 2024.

What is the P/E ratio for Evolent Health stock?

The price to earnings (P/E) ratio for Evolent Health (EVH) stock is 0 as of June 19, 2024.

Does Evolent Health stock pay dividends?

No, Evolent Health (EVH) stock does not pay dividends to its shareholders as of June 19, 2024.

When is the next Evolent Health dividend payment date?

Evolent Health (EVH) stock does not pay dividends to its shareholders.

What is the beta indicator for Evolent Health?

Evolent Health (EVH) has a beta rating of 1.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Evolent Health stock price target?

The target price for Evolent Health (EVH) stock is $41.77, which is NaN% below the current price of $. This is an average based on projections from 13 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Evolent Health stock

Buy or sell Evolent Health stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing